Gut microbiome alteration as a diagnostic tool and associated with inflammatory response marker in primary liver cancer
Gut microbiome alteration as a diagnostic tool and associated with inflammatory response marker in primary liver cancer is a paper indexed in PICO Portal from OpenAlex.
How many citations does Gut microbiome alteration as a diagnostic tool and associated with inflammatory response marker in primary liver cancer have?
Gut microbiome alteration as a diagnostic tool and associated with inflammatory response marker in primary liver cancer has 68 citations in the OpenAlex counts PICO Portal stores.
When was Gut microbiome alteration as a diagnostic tool and associated with inflammatory response marker in primary liver cancer published?
Gut microbiome alteration as a diagnostic tool and associated with inflammatory response marker in primary liver cancer has 2022 year in the PICO Portal index.
What is the open-access status of Gut microbiome alteration as a diagnostic tool and associated with inflammatory response marker in primary liver cancer?
Gut microbiome alteration as a diagnostic tool and associated with inflammatory response marker in primary liver cancer has closed oa status in the PICO Portal index.
What is the DOI of Gut microbiome alteration as a diagnostic tool and associated with inflammatory response marker in primary liver cancer?
The DOI for Gut microbiome alteration as a diagnostic tool and associated with inflammatory response marker in primary liver cancer is on the source record.
What is the PMID of Gut microbiome alteration as a diagnostic tool and associated with inflammatory response marker in primary liver cancer?
The PMID for Gut microbiome alteration as a diagnostic tool and associated with inflammatory response marker in primary liver cancer is on the source record.
What is the OpenAlex record for Gut microbiome alteration as a diagnostic tool and associated with inflammatory response marker in primary liver cancer?
The OpenAlex for Gut microbiome alteration as a diagnostic tool and associated with inflammatory response marker in primary liver cancer is on the source record.